
AI Protein Design Service Provider

Recently,World Artificial Intelligence Conference · Outstanding AI LeaderSAIL AwardTOP30The list was officially released.Leader in Advanced Artificial IntelligenceSAIL AwardAs a high-standard, international award in the field of artificial intelligence worldwide, it adheres to“Pursuing Excellence, Leading the Future"Concept: To discover world-leading artificial intelligence projects that enjoy high recognition and reputation and enhance human well-being, aiming to inspire technological breakthroughs, application innovations, and governance exploration, leading the intelligent transformation.
Qiming Venture Capital's portfolio company Xiaomi Group (01810.HK), Matwings Technology, Biren Technology, and Galaxy General ranked among the Outstanding AI LeadersSAIL AwardTOP30List.

Xiaomi Group
(XiaomiHyperAI: Large Model Intelligent Engine for the Entire Ecosystem of People, Vehicles, and Homes
Matwings Technology
(Protein Function Prediction and Metabolic Pathway Interaction AI Design Platform)
Biren Technology
(DistributedOCSAll-Optical Interconnect Chips and Supernode Application Innovation Solutions
Galaxy Universal
(Fully Synthetic Data PretrainingVLAEmbodied Intelligence Large Model)
Rong Deng
Leader in Advanced Artificial IntelligenceSAIL AwardTOP30List
Leader in Advanced Artificial IntelligenceSAIL AwardAdhering to Excellence(Superior), Empowerment(Applicative), Innovation(Innovative), Leading(Leading)The value concept, with the vision of "reconstructing the paradigm of human social development through intelligent technology," explores the information age.“Intelligent+”Benchmark.“SAIL”It also implies setting sail for the future, hoping that the sails of artificial intelligence will head towards a better tomorrow.
ComeSource |World Artificial Intelligence Conference
Qiming Venture Partners was founded in 2006.Currently, Qiming Venture Partners manages 11 US dollar funds and 7 RMB funds, with total managed assets under management reaching 9.5 billion US dollars. Since its inception, it has focused on investing in outstanding early-stage and growth-stage companies in the Technology and Consumer (T&C), Healthcare, and other industries.
To date, Qiming Venture Partners has invested in more than 580 rapidly growing innovative enterprises, of which over 210 have gone public on exchanges such as the New York Stock Exchange, NASDAQ, Hong Kong Stock Exchange, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through mergers and acquisitions. More than 80 of these enterprises have become unicorns or super unicorns recognized in their respective industries.
Among the companies invested in by Qiming Venture Partners, many have grown into the most influential companies in their respective fields, including Xiaomi Group (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH Robotics (09880.HK), WeRide (NASDAQ:WRD), Insta360 (688775.SH), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), Hithrone Medical (688617.SH), Sanyou Medical (688085.SH), AmoyDx (300685.SZ), Berry Genomics (000710.SZ), SinoCellTech (688520.SH), Yuanxin Technology, Insilico Medicine, Yilian Biotech, LaNova Medicines, Zhipu AI, Step Stars, Biren Technology, etc.